Australia’s central bank to get new rate-setting board under review shake up

By Wayne Cole SYDNEY (Reuters) -Australia’s central bank is expected to get a new specialist board to manage monetary policy that will give independent expert members more responsibility for setting interest rates, a dilution of the bank’s traditional power over policy. A 272-page review of the Reserve Bank of Australia (RBA) released on Thursday outlined…

Read More

BMW skids into ice cream melee at Shanghai auto show

SHANGHAI (Reuters) – Chinese internet users berated German automaker BMW on Thursday, accusing it of discrimination at the Shanghai auto show amid claims workers at its Mini booth favoured foreign over domestic visitors during an ice cream giveaway promotion. Mini apologised for the incident in question, saying in a statement on its official Weibo account…

Read More

‘Peak Fed’ aggravates U.S. debt ceiling strains: McGeever

By Jamie McGeever ORLANDO, Florida (Reuters) -Markets are struggling to disentangle their assumption the Federal Reserve will quickly reverse its final rate rise within months from anxiety around a summer debt ceiling showdown – and suspect rates pricing may be skewed by the latter. Policymakers have indicated, via their median ‘dot plot’ projections and public…

Read More

Investors warn big consumer firms over price hikes as competitors gain

By Richa Naidu and Jessica DiNapoli LONDON/NEW YORK (Reuters) – Consumer goods companies like P&G, Unilever and Nestle should start easing price increases as supply chain costs decline, investors told Reuters, worried that further hikes could hit market share and margin growth. The makers of everything from soap and ice cream to condoms and cleaning…

Read More

GSK-spinoff Haleon forecasts 2023 organic revenue growth at top-end of view

(Reuters) – Consumer healthcare group Haleon expects 2023 organic revenue growth towards the upper end of its 4%-6% forecast, it said on Thursday, on strong demand and the restocking of its respiratory health products due to a bad cold and flu season. The company, the world’s biggest standalone consumer health business that sells non-prescription drugs,…

Read More

USTR’s Tai: Indo-Pacific trade talks could see results this year

TOKYO (Reuters) – U.S. Trade Representative Katherine Tai said on Thursday Indo-Pacific Economic Framework (IPEF) trade negotiations are progressing “at a very quick pace” and she expects results from the talks as early as by the end of the year. The United States and 13 Indo-Pacific countries last year launched negotiations on IPEF, Washington’s first…

Read More